601607.SS · 上海医药
China A-shares · RS rating 82 · As of 2026-10-14
| Price | 16.78 CNY |
|---|---|
| 1-day change | +0.5% |
| RS rating (overall / 1M / 3M / 12M) | 82 / 81 / 61 / 63 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 38 / 35 |
| Industry group (rank) | Medical-Outpnt/Hm Care (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -4.1% |
| Distance from 52-week high | +8.8% |
| Market cap (USD) | $9.1B |